Paper: arXiv 2410.02709

Authors: Tamen Jadad-Garcia, Alejandro R. Jadad

Abstract

Introduction: As digital health evolves, identifying factors that drive success is crucial. This study examines how reimbursement billing codes affect the long-term financial performance of digital health companies on U.S. stock markets, addressing the question: What separates the winners from the rest? Methods: We analyzed digital health companies that went public on U.S. stock exchanges between 2010 and 2021, offering products or services aimed at improving personal health or disease management within the U.S. market. A search using Google and existing IPO lists identified eligible companies. They were categorized based on the presence or absence of billing codes at the time of their initial public offering (IPO). Key performance indicators, including Compound Annual Growth Rate (CAGR), relative performance to benchmark indices, and market capitalization change, were compared using Mann-Whitney U and Fisher’s Exact tests. Results: Of the 33 companies analyzed, 15 (45.5%) had billing codes at IPO. The median IPO price was $17.00, with no significant difference between groups. Those with billing codes were 25.5 times more likely to achieve a positive CAGR. Their median market capitalization increased 56.3%, compared to a median decline of 80.1% for those without billing codes. All five top performers, in terms of CAGR, had billing codes at IPO, whereas nine of the ten worst performers lacked them. Companies without billing codes were 16 times more likely to experience a drop in market capitalization by the study’s end. Conclusion: Founders, investors, developers and analysts may have overestimated consumers’ willingness to pay out-of-pocket or underestimated reimbursement complexities. As the sector evolves, especially with AI-driven solutions, stakeholders should prioritize billing codes to ensure sustainable growth, financial stability, and maximized investor returns.

Complexity vs Empirical Score

  • Math Complexity: 1.0/10
  • Empirical Rigor: 6.5/10
  • Quadrant: Street Traders — empirical and applied, lower math complexity

Why this score: The paper uses only basic descriptive statistics and non-parametric tests (Mann-Whitney U, Fisher’s Exact) with no advanced mathematical modeling or derivations, placing it low on math complexity. However, it is empirically grounded in a defined sample of 33 IPOs with clear financial metrics (CAGR, market cap changes), statistical significance testing, and a reproducible search strategy, indicating moderate to high empirical rigor for a finance/economics-style study.

Research Flowchart

  flowchart TD
  A["Research Goal"] -->|"What separates<br>digital health winners?"| B["Methodology"]
  
  subgraph B ["Methodology"]
      B1["Identify Digital Health IPOs<br>2010-2021"] --> B2["Group by<br>Reimbursement Status"]
      B2 --> B3["Compare Financial Metrics<br>CAGR, Market Cap Change"]
  end
  
  B --> C["Data: 33 Companies"]
  C --> D["Analysis<br>Statistical Tests: Mann-Whitney U, Fisher's Exact"]
  
  D --> E
  
  subgraph E ["Key Findings"]
      E1["Top 5 Performers<br>All had billing codes"]
      E2["Bottom 9 of 10<br>Lacked billing codes"]
      E3["25.5x more likely<br>positive CAGR<br>with codes"]
      E4["Median Market Cap Change<br>With Codes: +56.3%<br>Without Codes: -80.1%"]
  end

Evidence Card

What the authors claim, on what data, and who has checked it. Read from the paper's own text by a language model: every quote is verbatim, nothing was re-run. How to read this card

Proposes

The paper proposes that the presence of reimbursement billing codes at IPO is a key factor driving long‑term financial success of digital health companies.

Source sentence
We have focused, specifically, on the impact of the presence or absence of such billing codes on the success or failure of digital companies at the time of their initial public offering (IPO).

Assumes 3

  • IPOs provide a transparent and mature sample suitable for studying long‑term performance factors. market
    Source sentence
    On the other hand, we considered IPOs as ideal for studying the impact of factors such as billing codes on the success or failure of digital health companies due to several unique characteristics.
  • Having a billing code at IPO confers a competitive edge that enhances long‑term prospects. other
    Source sentence
    Our choice was driven by the hypothesis that having billing codes in place at the time of an IPO provides a competitive edge for a company in the market and significantly enhances its prospects for long‑term success.
  • The existence of a CPT code or explicit reimbursement statement accurately indicates a billing code for the company. data
    Source sentence
    A company was deemed to have a reimbursement code for its procedures or services if, in any of the above sources, a Current Procedural Terminology (CPT) code was mentioned, or if there was an explicit statement about the eligibility of the company’s procedures or services for reimbursement...

Data

  • Yahoo Finance · Yahoo market-prices public
    up to June 30, 2024 · digital health IPOs 2010‑2021
    Source sentence
    The data about each of the companies and their stock values, and the composite indices were obtained from publicly available databases, namely Yahoo Finance and Stock Analysis.
  • Stock Analysis · Stock Analysis market-prices public
    up to June 30, 2024 · digital health IPOs 2010‑2021
    Source sentence
    The data about each of the companies and their stock values, and the composite indices were obtained from publicly available databases, namely Yahoo Finance and Stock Analysis.

Costs

Not applicable The paper reports no trading or execution result.

Finds 5

  • Companies with billing codes were 25.5 times more likely to achieve a positive CAGR than those without. performance
    Source sentence
    This made companies with billing codes 25.5 times more likely to experience positive growth than those that lacked a billing code at the time of their IPO (p = 0.001).
  • Median market capitalization increased 56.3% for firms with billing codes versus a median decline of 80.1% for firms without. performance
    Source sentence
    Their median market capitalization increased 56.3%, compared to a median decline of 80.1% for those without billing codes.
  • All five top performers (by CAGR) had billing codes at IPO, while nine of the ten worst performers lacked them. performance
    Source sentence
    five companies had billing codes at the time of their IPO, while none of the 18 without billing code did (p = 0.012).
  • Firms with billing codes were 25.5 times more likely to have a stock price above the IPO price by June 30, 2024. performance
    Source sentence
    digital health companies with billing codes were 25.5 times more likely to have a stock price above their IPO price by June 30, 2024, compared to companies without billing codes (95% CI of the odds ratios from 2.65 to 245.84, p = 0.0015).
  • Companies without billing codes were 16 times more likely to experience a drop in market capitalization by the study’s end. performance
    Source sentence
    Companies without billing codes were 16 times more likely to experience a drop in market capitalization by the study's end.

Checked by others

No other paper in the archive has been found to support or contradict these findings (compared with 13 related papers). Coverage is partial, so this is neither replication nor refutation.

Code

No repository by the authors found in the paper.

Extracted 2026-11-14 · same card as JSON · A language model chose these items: check the source sentence before relying on one.